Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- NURO
- Price
- 4.58
- Stock movement up
- +0.22 (5.05%)
- Company name
- NeuroMetrix Inc
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Medical Devices
- Market cap
- 9.43M
- Ent value
- -
- Price/Sales
- -
- Price/Book
- -
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -2.55%
- 3 year return
- -44.40%
- 5 year return
- -26.28%
- 10 year return
- -48.17%
Last updated: 2025-09-15
DIVIDENDS
NURO does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | - |
| EV to Sales | - |
FINANCIALS
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 4.36 |
| Daily high | 4.69 |
| Daily low | 4.33 |
| Daily Volume | 36K |
| All-time high | 3722342.40 |
| 1y analyst estimate | 50.00 |
| Beta | 1.83 |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | 28 Mar 2007 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| NURO | S&P500 | |
| Current price drop from All-time high | -100.00% | -8.89% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 1 May 2025 | 9 Mar 2009 |
| Avg drop from high | -88.33% | -10.99% |
| Avg time to new high | 73 days | 12 days |
| Max time to new high | 4772 days | 1805 days |
COMPANY DETAILS
Marketcap
9.43M
Marketcap category
Small-cap
Description
NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain. The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.
Employees
13
Website
Investor relations
-
SEC filings
CEO
Shai N. Gozani
Country
USA
City
Woburn
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner